CYBI should outperform the market going into the future from around $6.00 per share. This pitch was written on 4/18/07 and they just gave up on litigation concerning a $2.8 million patent lawsuit. Now that the suit is settled, they’re left with a P/E of 5.07 and terrific potential. While their net income has been rather volatile, sales have increased steadily over the last five years. Going from $81,527 to $126,924, they’ve had a respectable average of 12% sales growth. Coupled with this growth, their cash inflows from operations are fairly hefty with negligible debt to contend with. They have high gross margins at 36.78% and EBITDA margins of 10.35%, which should help the growth momentum as they plow retained earnings back into the business. I believe this may be a locomotive just beginning to build steam. With a return on invested capital of 52%, the reinvesting should establish CYBI as a bigger, badder, bolder player in their niche.